Trial
NCT02268201
A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Astellas Pharma China, Inc.
Collaborators
—
Condition
Kidney Transplant Recipients
Intervention
Advagraf
Why stopped
Due to difficulty enrolling patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-01